Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Drug symbols : Fenc save search
Fennec Pharmaceuticals Announces PEDMARK® (sodium thiosulfate injection) Receives Orphan Drug Exclusivity from U.S. FDA
Published: 2023-01-31 (Crawled : 13:20) - biospace.com/
FNCTF | News | $11.0354 -20.84% 320
|
Communications
|
| O: 0.68%
H: 0.0%
C: 0.0%
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: -0.21%
H: 8.3%
C: 6.49%
pedmark fda pharmaceuticals drug
Fennec Pharmaceuticals Announces FDA Acceptance for Filing of New Drug Application Resubmission for PEDMARK™
Published: 2022-04-27 (Crawled : 11:00) - biospace.com/
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: -1.44%
H: 1.94%
C: -7.94%
fda drug application resubmission
FENNEC PHARMACEUTICALS RESUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINSTRATION FOR PEDMARKTM
Published: 2022-03-24 (Crawled : 08:00) - fennecpharma.com
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: 0.0%
H: 1.97%
C: -6.41%
application drug food
Fennec Pharmaceuticals Receives Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
Published: 2021-11-30 (Crawled : 09:00) - fennecpharma.com
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: -9.92%
H: 0.0%
C: 0.0%
new drug fda solid tumors application drug
Fennec Pharmaceuticals Expects to Receive Complete Response Letter from the FDA for its New Drug Application for PEDMARK™ to Prevent Ototoxicity Associated with Cisplatin in Pediatric Patients with Localized, Non-Metastatic, Solid Tumors
Published: 2021-11-29 (Crawled : 12:00) - biospace.com/
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: -50.05%
H: 0.0%
C: 0.0%
new drug fda solid tumors application drug
FENNEC PHARMACEUTICALS ANNOUNCES FDA ACCEPTANCE OF NEW DRUG APPLICATION RESUBMISSION FOR PEDMARKTM
Published: 2021-06-22 (Crawled : 15:00) - fennecpharma.com
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: 4.07%
H: 2.17%
C: 1.01%
new drug fda fda acceptance drug submission application resubmission
Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for PEDMARK™
Published: 2021-06-22 (Crawled : 12:00) - biospace.com/
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: 4.07%
H: 2.17%
C: 1.01%
new drug fda fda acceptance drug submission application resubmission
FENNEC PHARMACEUTICALS RESUBMITS NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR PEDMARKTM
Published: 2021-05-28 (Crawled : 14:00) - fennecpharma.com
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: 2.17%
H: 8.07%
C: 4.39%
new drug food drug application
Fennec Pharmaceuticals Resubmits New Drug Application to U.S. Food and Drug Administration for PEDMARK™
Published: 2021-05-28 (Crawled : 11:00) - globenewswire.com
FENC M | $10.5 -3.05% -3.14% 100K
|
Health Technology
|
| O: 2.17%
H: 8.07%
C: 4.39%
new drug food drug application
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | News | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.